Robin Hood Ventures

Robin Hood Ventures is an angel investor group based in Philadelphia, Pennsylvania, established in 1999. The organization focuses on early-stage, high-growth companies primarily in the Greater Philadelphia region. It provides capital, mentoring, and valuable connections to assist entrepreneurs in building successful businesses. Typically, Robin Hood Ventures invests between $250,000 and $500,000, often collaborating with other angel investors, institutions, and venture capitalists within its network. The firm has a diverse investment portfolio, spanning various sectors, including information technology services, software, life sciences, hard technology, consumer products, and financial technology. Since its inception, Robin Hood Ventures has invested in over 45 companies, emphasizing a hands-on approach to helping businesses achieve their potential.

Donna Cordner

Managing Partner

Allen Fogel

Partner

Sasha Schrode

Partner at Robin Hood Ventures

152 past transactions

Integrated Reality Labs

Funding Round in 2025
Integrated Reality Labs (IRL Inc.) builds integrated reality (IR) games and tools that enhance play in the real world. Our patent pending Integrated Reality Technology Platform leverages UWB, bluetooth + mobile location services & other device sensors to power all of IRL’s products, starting with SLAP. SLAP is a mobile app that digitally transforms IRL games - like Assassin, HvZ, Capture the Flag, Manhunt & Tag - making them more fun and easier to play anytime, anywhere, and with anyone. IRL inc is in the process of using the IRTP to empower end users to create, share, and monetize their own mobile powered real world games... a la the Roblox if IRL Games.

Vessl Prosthetics

Pre Seed Round in 2025
Vessl Prosthetics is a prosthetics firm that is driven by the idea of empowering amputees and their champions to overcome challenges and realize their full potential. The objective is to revolutionize how amputees engage with prosthetic devices by developing new, inexpensive, and accessible alternatives.

BrilliantPad

Funding Round in 2024
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents.

Virion Therapeutics

Funding Round in 2024
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Vytala

Pre Seed Round in 2024
Vytala is a food tech firm focused on improving nutrition through innovative solutions.

Accencio

Funding Round in 2024
Accencio is an intellectual property strategy and intelligence company focused on the molecular-based industry and research. It has developed an IP intelligence platform that offers a comprehensive understanding of targeted intellectual property areas, helping clients identify strategic opportunities and potential threats. The platform features unique, interactive visualizations and analytical tools that facilitate in-depth analysis and consulting services. Accencio aims to provide critical insights and support for obtaining intellectual property rights, enabling clients to address essential business questions more efficiently and cost-effectively throughout the research and development, patenting, and licensing processes.

Ophidion

Funding Round in 2024
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

Epoxy.ai

Funding Round in 2024
Epoxy.ai is a technology developer specializing in sports personalization solutions that cater to media and gaming companies. The company offers tools that utilize artificial intelligence and machine learning to provide contextually relevant data, enhancing customer acquisition, engagement, and retention. Through its suite of licensable, easily integrated application programming interfaces (APIs) and plug-and-play components, Epoxy.ai enables clients to automate complex workflows and gain actionable insights into customer behavior across various touchpoints. This technology supports sports leagues, betting companies, and media entities in effectively connecting with their audiences and evolving their strategies within the global sports media and gaming industry.

Fuego

Funding Round in 2024
Fuego is a global dance-inspired athleisure and lifestyle brand that specializes in the design and manufacture of innovative footwear. The company offers a line of patented sneakers engineered for both dancing and everyday wear, featuring sole technology that supports movement on various surfaces. Fuego's sneakers are lightweight, shock-absorbing, flexible, and built with a minimalistic design. They are also vegan, spill-proof, and water-resistant, catering to the needs of dancers and fitness enthusiasts alike. Fuego's products are endorsed by top dancers worldwide and have been showcased in collaborations with notable figures in the dance community. With a presence in 120 countries, the brand aims to blend functionality with style, allowing users to seamlessly transition from the street to the dance studio.

S2N Health

Seed Round in 2024
S2N Health is a consulting firm that specializes in providing strategy consulting services and SaaS solutions tailored for the medical technology sector. Established in 2011, the company has worked with over 160 organizations, ranging from startups to large multinational firms, offering insights and analytics that inform critical product, commercial, and business decisions. S2N Health supports clients across various stages, including product development, market entry, sales acceleration, and strategic partnerships. A key offering is RepSignal, an AI-driven SaaS solution launched in 2022, which provides medtech commercial teams with on-demand customer insights and intelligence, allowing them to effectively target and engage clinical customers. The firm aims to facilitate the growth and success of medical technology innovators by leveraging a network of experts in regulatory, reimbursement, and other relevant disciplines.

FEMSelect

Convertible Note in 2024
FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.

BiologicsMD

Corporate Round in 2024
BiologicsMD, Inc. is a therapeutic development company based in Fayetteville, Arkansas, established in 2010. The company specializes in creating targeted therapies for hair loss and severe bone disorders. Its product pipeline includes BMD-1141, a hair cycle stimulator aimed at restoring normal hair growth and preventing hair loss by stimulating the hair cycle, and BMD-1231, a bone graft substitute designed for spinal fusion procedures. BiologicsMD focuses on developing recombinant fusion proteins that deliver potent stimulatory effects directly to specific receptors at the site of disease, allowing for sustained therapeutic exposure with either a single dose or infrequent dosing regimens. The company is also exploring various formulation and delivery methods for parenteral, local, and topical administration of its therapies.

Burrow

Convertible Note in 2024
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Deepwave Digital

Convertible Note in 2024
Deepwave Digital, Inc. specializes in manufacturing artificial intelligence (AI)-based hardware and software solutions tailored for radio frequency (RF) and wireless systems. Established in 2017 and headquartered in Philadelphia, Pennsylvania, the company provides integrated solutions that enhance the capabilities of RF systems by relocating the AI computation engine closer to the signal edge. This innovative approach minimizes network bandwidth usage, reduces latency, and decreases reliance on manual analysis. Deepwave Digital's product lineup includes the Artificial Intelligence Radio Transceiver (AIR-T), a software-defined radio, as well as software tools like AirPack, AirStack Sandbox, and Spectrum Sensing, which help clients detect and identify signals in their spectral environment. With a team of RF industry experts boasting over fifty years of combined experience, Deepwave Digital serves both commercial and defense sectors, enabling customers to develop custom AI and high-performance computing systems using trusted software solutions.

Proscia

Series C in 2024
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Biomeme

Convertible Note in 2024
Biomeme Inc., founded in 2012 and based in Philadelphia, Pennsylvania, offers an innovative platform for molecular DNA diagnostics and on-site disease tracking through a smartphone. The company's technology includes a real-time PCR thermocycler that connects to an iPhone, alongside a docking station and a mobile app for controlling the system and analyzing results. Biomeme provides targeted test kits that allow users to prepare samples and identify pathogens or diseases based on their specific DNA or RNA signatures. This end-to-end DNA testing solution enables mobile testing at the point-of-need across various sectors, including healthcare, agriculture, veterinary medicine, environmental monitoring, and education. By facilitating lab-grade molecular processes, Biomeme enhances real-time disease surveillance and diagnostics.

GABA Therapeutics

Funding Round in 2024
GABA Therapeutics is focused on developing GRX-917, a medication designed for the treatment of anxiety, depression, and various neuropsychiatric and neurological disorders. This drug features a dual mechanism of action, offering a rapid onset of effects similar to benzodiazepines while minimizing side effects. By targeting a wide range of conditions, GABA Therapeutics aims to provide effective relief for patients suffering from life-altering neuropsychiatric, neurologic, and pain disorders.

OcuTerra Therapeutics

Convertible Note in 2024
OcuTerra Therapeutics, Inc. is focused on developing innovative therapies for ophthalmic diseases that currently lack effective treatment options. The company is working on a novel eye drop specifically designed to address diabetic eye disease. This eye drop functions as an integrin inhibitor and is engineered to reach the back of the eye, allowing healthcare professionals to better assist patients in preventing vision loss associated with this condition. Through its advancements, OcuTerra aims to improve outcomes for individuals suffering from serious eye diseases.

Vesteck

Convertible Note in 2024
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

BrilliantPad

Convertible Note in 2024
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents.

Illumina Radiopharmaceuticals

Venture Round in 2023
Illumina Radiopharmaceuticals

Medcura

Convertible Note in 2023
Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

SessionGuardian

Seed Round in 2023
SessionGuardian is a leading provider of cybersecurity software focused on identity access control and authentication for hybrid teams managing highly sensitive data. The company's innovative software delivers continuous biometric identity verification for remote users, monitoring their identity from the moment they log on until they log off. This real-time authentication process helps businesses safeguard against data breaches while maintaining efficient workflows. By prioritizing endpoint security, SessionGuardian addresses the critical need for robust protection in an increasingly remote work environment.

Fuego

Convertible Note in 2023
Fuego is a global dance-inspired athleisure and lifestyle brand that specializes in the design and manufacture of innovative footwear. The company offers a line of patented sneakers engineered for both dancing and everyday wear, featuring sole technology that supports movement on various surfaces. Fuego's sneakers are lightweight, shock-absorbing, flexible, and built with a minimalistic design. They are also vegan, spill-proof, and water-resistant, catering to the needs of dancers and fitness enthusiasts alike. Fuego's products are endorsed by top dancers worldwide and have been showcased in collaborations with notable figures in the dance community. With a presence in 120 countries, the brand aims to blend functionality with style, allowing users to seamlessly transition from the street to the dance studio.

Simply Good Jars

Convertible Note in 2023
Simply Good Jars is a B-Corp company focused on providing healthy, ready-to-eat meals through reusable and returnable packaging. The company utilizes smart refrigerated kiosks strategically placed in offices, transit centers, universities, and health systems to deliver its chef-crafted food products to local communities. Committed to sustainability, Simply Good Jars aims to change consumer habits by implementing zero-waste practices in its operations. For every jar returned for reuse, the company supports food assistance efforts, ensuring that no packaging materials contribute to landfill waste. By promoting eco-friendly consumption, Simply Good Jars strives to offer convenient meal options that are beneficial for both individuals and the planet.

Epoxy.ai

Seed Round in 2023
Epoxy.ai is a technology developer specializing in sports personalization solutions that cater to media and gaming companies. The company offers tools that utilize artificial intelligence and machine learning to provide contextually relevant data, enhancing customer acquisition, engagement, and retention. Through its suite of licensable, easily integrated application programming interfaces (APIs) and plug-and-play components, Epoxy.ai enables clients to automate complex workflows and gain actionable insights into customer behavior across various touchpoints. This technology supports sports leagues, betting companies, and media entities in effectively connecting with their audiences and evolving their strategies within the global sports media and gaming industry.

Wavely Diagnostics

Seed Round in 2023
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Verdafresh

Series B in 2023
Verdafresh specializes in flexible packaging solutions that preserve the freshness of food while emphasizing recyclability. The company manufactures mono-material packaging that incorporates barrier coatings on films, providing an effective alternative to traditional materials like EVOH. This innovative approach not only helps extend the shelf life of food products but also addresses concerns related to plastic waste. By focusing on natural and abundant materials, Verdafresh aims to deliver competitive and sustainable packaging options for its clients, ensuring both quality preservation and environmental responsibility.

Ophidion

Convertible Note in 2023
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

ChargeItSpot

Series A in 2023
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.

Hanimune Therapeutics

Seed Round in 2023
Hanimune Therapeutics is a biotechnology company that seeks to prevent and treat food allergies by using nature-based solutions. It is also developing novel treatments for food allergies that utilize the tolerogenic immune system, which is part of the immune system that prevents harmful reactions to harmless substances.

Measure Studio

Seed Round in 2023
Measure Studio operates a content intelligence engine that aids users in developing data-driven social media strategies. The platform serves digital publishers, brands, agencies, and influencers by providing a secure environment to consolidate and analyze social media data. By facilitating better management of social media analytics across various platforms, Measure Studio empowers its users to create more effective and engaging content based on insights derived from their data.

Cooler Heads

Venture Round in 2023
Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Lia

Convertible Note in 2023
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

LuxTech

Convertible Note in 2023
LUXTECH, LLC is a Philadelphia-based company that specializes in designing, engineering, and manufacturing LED module solutions for lighting fixture manufacturers. Established in 2012, the company focuses on specification-grade LED modules, which include a range of products such as LINEAR Dynamic White, COB Warm Dim, and FLEX LED modules. LUXTECH caters to various industries, including entertainment, education, healthcare, and cultural sectors, by providing modules that support human-centric architectural lighting applications. The company assists original equipment manufacturers (OEMs) in rapidly developing reliable, energy-efficient LED fixtures to meet market demands. With a commitment to innovation and efficiency, LUXTECH also offers custom designs and consultation services, enabling partners to retrofit existing fixtures or create new ones. Their products are designed for diverse applications such as troffers, downlights, and outdoor lighting, featuring long lifetimes and low energy consumption. LUXTECH’s LED modules are built using high-quality components, backed by a five-year warranty, ensuring reliability and performance in the lighting industry.

Vesteck

Venture Round in 2023
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

Beckon Ice Cream

Seed Round in 2022
Beckon Ice Cream specializes in producing premium lactose-free ice cream made from real milk and cream. The company utilizes lactase enzyme to ensure its products are suitable for lactose-intolerant consumers. Beckon’s ice cream is crafted with only six natural ingredients, avoiding any gums, stabilizers, or artificial additives. The product line includes a variety of flavors, such as vanilla, mint chip, sea salt chocolate chip, peanut butter cup, and dark chocolate brownie, available in formats like pints and quarts. By focusing on clean-label products, Beckon caters to those seeking quality dairy alternatives without compromising on flavor.

Fuego

Seed Round in 2022
Fuego is a global dance-inspired athleisure and lifestyle brand that specializes in the design and manufacture of innovative footwear. The company offers a line of patented sneakers engineered for both dancing and everyday wear, featuring sole technology that supports movement on various surfaces. Fuego's sneakers are lightweight, shock-absorbing, flexible, and built with a minimalistic design. They are also vegan, spill-proof, and water-resistant, catering to the needs of dancers and fitness enthusiasts alike. Fuego's products are endorsed by top dancers worldwide and have been showcased in collaborations with notable figures in the dance community. With a presence in 120 countries, the brand aims to blend functionality with style, allowing users to seamlessly transition from the street to the dance studio.

FEMSelect

Series B in 2022
FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.

Epoxy.ai

Venture Round in 2022
Epoxy.ai is a technology developer specializing in sports personalization solutions that cater to media and gaming companies. The company offers tools that utilize artificial intelligence and machine learning to provide contextually relevant data, enhancing customer acquisition, engagement, and retention. Through its suite of licensable, easily integrated application programming interfaces (APIs) and plug-and-play components, Epoxy.ai enables clients to automate complex workflows and gain actionable insights into customer behavior across various touchpoints. This technology supports sports leagues, betting companies, and media entities in effectively connecting with their audiences and evolving their strategies within the global sports media and gaming industry.

AnaOno

Seed Round in 2022
AnaOno is an apparel brand focused on creating unique intimates and loungewear for women who have undergone breast surgery, including mastectomies and breast reconstructions, often due to cancer diagnoses. The company designs its products to accommodate different breast shapes and surgical needs, crafting wire-free undergarments made from soft materials that prioritize comfort. With an emphasis on feminine details and diverse silhouettes, AnaOno offers a range of options to meet the specific needs of women living with these conditions, ensuring they have access to stylish and functional apparel.

Medcura

Venture Round in 2022
Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

SessionGuardian

Seed Round in 2022
SessionGuardian is a leading provider of cybersecurity software focused on identity access control and authentication for hybrid teams managing highly sensitive data. The company's innovative software delivers continuous biometric identity verification for remote users, monitoring their identity from the moment they log on until they log off. This real-time authentication process helps businesses safeguard against data breaches while maintaining efficient workflows. By prioritizing endpoint security, SessionGuardian addresses the critical need for robust protection in an increasingly remote work environment.

Thermalin

Venture Round in 2022
Thermalin, Inc. is a biotechnology company based in Cleveland, Ohio, founded in 2010, that specializes in developing innovative insulin therapies for individuals with Type 1 and Type 2 diabetes. The company aims to disrupt the insulin and insulin delivery market with its first-in-class, ultra-rapid acting insulin, which is stabilized and highly concentrated. This new insulin formulation is designed for use in a disposable, postage-stamp-sized glucose management system and can also be utilized in existing insulin pumps. In addition to its lead program, Thermalin is exploring partnerships to develop no-cold-chain basal and mix insulins, as well as glucose-responsive insulins. By creating insulin analogs that do not require refrigeration and are rapidly absorbed, Thermalin seeks to reduce the burden of insulin therapy, thereby improving patient adherence and health outcomes.

Illumina Radiopharmaceuticals

Venture Round in 2022
Illumina Radiopharmaceuticals

BiologicsMD

Venture Round in 2022
BiologicsMD, Inc. is a therapeutic development company based in Fayetteville, Arkansas, established in 2010. The company specializes in creating targeted therapies for hair loss and severe bone disorders. Its product pipeline includes BMD-1141, a hair cycle stimulator aimed at restoring normal hair growth and preventing hair loss by stimulating the hair cycle, and BMD-1231, a bone graft substitute designed for spinal fusion procedures. BiologicsMD focuses on developing recombinant fusion proteins that deliver potent stimulatory effects directly to specific receptors at the site of disease, allowing for sustained therapeutic exposure with either a single dose or infrequent dosing regimens. The company is also exploring various formulation and delivery methods for parenteral, local, and topical administration of its therapies.

Proscia

Series C in 2022
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Atrin Pharmaceuticals

Venture Round in 2022
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of innovative cancer treatments. Founded in 2011, the company is developing its lead drug candidates, ATRN-502, a p53 activator, and ATRN-507, a dual ligand that selectively targets cancer cells. Atrin is also advancing a proprietary platform called Atrize, which utilizes phenotypic FACS-based screening for rapid identification of effective drug candidates and evaluation of personalized medicine approaches. The company's research aims to address cancers linked to synthetic lethality and deregulated DNA damage response, with a focus on creating treatments that are effective against cancer cells while minimizing impact on healthy cells. Through its innovative methodologies, Atrin Pharmaceuticals seeks to change the landscape of cancer therapy.

ChargeItSpot

Venture Round in 2022
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.

Vertiq

Series B in 2022
Vertiq specializes in high-performance propulsion solutions for aerial vehicles and mobile robots. The company designs ultra-compact, integrated motors and electronic speed controllers (ESC) that feature embedded position sensors. These innovations, combined with advanced motor calibration and control software, provide vehicles with significant performance enhancements, such as extended flight times, improved maneuverability, and increased reliability. By optimizing motor performance and controllability, Vertiq enables its clients to elevate the capabilities of their vehicles, making them suitable for a range of applications in various industries.

Simply Good Jars

Seed Round in 2022
Simply Good Jars is a B-Corp company focused on providing healthy, ready-to-eat meals through reusable and returnable packaging. The company utilizes smart refrigerated kiosks strategically placed in offices, transit centers, universities, and health systems to deliver its chef-crafted food products to local communities. Committed to sustainability, Simply Good Jars aims to change consumer habits by implementing zero-waste practices in its operations. For every jar returned for reuse, the company supports food assistance efforts, ensuring that no packaging materials contribute to landfill waste. By promoting eco-friendly consumption, Simply Good Jars strives to offer convenient meal options that are beneficial for both individuals and the planet.

Burrow

Series C in 2022
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Lia

Seed Round in 2022
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

Beckon Ice Cream

Seed Round in 2022
Beckon Ice Cream specializes in producing premium lactose-free ice cream made from real milk and cream. The company utilizes lactase enzyme to ensure its products are suitable for lactose-intolerant consumers. Beckon’s ice cream is crafted with only six natural ingredients, avoiding any gums, stabilizers, or artificial additives. The product line includes a variety of flavors, such as vanilla, mint chip, sea salt chocolate chip, peanut butter cup, and dark chocolate brownie, available in formats like pints and quarts. By focusing on clean-label products, Beckon caters to those seeking quality dairy alternatives without compromising on flavor.

Cooler Heads

Seed Round in 2021
Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

BrilliantPad

Series D in 2021
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents.

Vesteck

Series A in 2021
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

Medcura

Series A in 2021
Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

OcuTerra Therapeutics

Series B in 2021
OcuTerra Therapeutics, Inc. is focused on developing innovative therapies for ophthalmic diseases that currently lack effective treatment options. The company is working on a novel eye drop specifically designed to address diabetic eye disease. This eye drop functions as an integrin inhibitor and is engineered to reach the back of the eye, allowing healthcare professionals to better assist patients in preventing vision loss associated with this condition. Through its advancements, OcuTerra aims to improve outcomes for individuals suffering from serious eye diseases.

Intrommune Therapeutics

Series A in 2021
Intrommune Therapeutics is a clinical-stage biotechnology company focused on developing safe and effective treatments for food allergies. The company’s Oral Mucosal Immunotherapy (OMIT) platform utilizes a specially formulated toothpaste that allows patients to safely expose their immune systems to allergenic proteins while maintaining oral hygiene. The primary product under development, INT301, targets peanut allergy, addressing a significant unmet need in a market with limited treatment options. Currently, only one FDA-approved product for food allergies exists, which requires patients to ingest peanut protein, a method that many find difficult and risky. Intrommune's innovative approach aims to provide a more accessible and manageable solution for patients and their families, reducing the fear associated with food allergies. The company is conducting a Phase 1b study for INT301, with important developmental milestones expected in the coming year.

Sonnest

Series A in 2021
Sonnest is a clinical healthcare company focused on myocardium-related solutions. It specializes in developing an electrically sensitive imaging agent that assesses and monitors the heart's perfusion, structure, and function. This innovative agent activates through ultrasound and responds to the heart's local electric field, indicating the viability of heart tissue. By providing advanced imaging technology, Sonnest aims to enhance patient care and clinical outcomes. The company addresses customer inquiries through various channels, including phone, email, and online applications, ensuring comprehensive support for healthcare professionals.

Deepwave Digital

Seed Round in 2020
Deepwave Digital, Inc. specializes in manufacturing artificial intelligence (AI)-based hardware and software solutions tailored for radio frequency (RF) and wireless systems. Established in 2017 and headquartered in Philadelphia, Pennsylvania, the company provides integrated solutions that enhance the capabilities of RF systems by relocating the AI computation engine closer to the signal edge. This innovative approach minimizes network bandwidth usage, reduces latency, and decreases reliance on manual analysis. Deepwave Digital's product lineup includes the Artificial Intelligence Radio Transceiver (AIR-T), a software-defined radio, as well as software tools like AirPack, AirStack Sandbox, and Spectrum Sensing, which help clients detect and identify signals in their spectral environment. With a team of RF industry experts boasting over fifty years of combined experience, Deepwave Digital serves both commercial and defense sectors, enabling customers to develop custom AI and high-performance computing systems using trusted software solutions.

Beckon Ice Cream

Angel Round in 2020
Beckon Ice Cream specializes in producing premium lactose-free ice cream made from real milk and cream. The company utilizes lactase enzyme to ensure its products are suitable for lactose-intolerant consumers. Beckon’s ice cream is crafted with only six natural ingredients, avoiding any gums, stabilizers, or artificial additives. The product line includes a variety of flavors, such as vanilla, mint chip, sea salt chocolate chip, peanut butter cup, and dark chocolate brownie, available in formats like pints and quarts. By focusing on clean-label products, Beckon caters to those seeking quality dairy alternatives without compromising on flavor.

Cooler Heads

Convertible Note in 2020
Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

FEMSelect

Convertible Note in 2020
FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.

Beckon

Venture Round in 2020
Beckon, Inc. offers omnichannel analytics software designed to provide marketers with performance analytics, visualization, and reporting solutions. Founded in 2011 and based in San Mateo, California, the company operates as a subsidiary of Aclate, Inc. Beckon's software-as-a-service platform integrates marketing data to deliver dashboards and scorecards that facilitate cross-channel marketing intelligence. The platform emphasizes data management and visibility into marketing performance, enabling users to analyze their campaigns in real time. It provides automated tools for campaign planning and offers key performance indicators to help marketers optimize their strategies, maximize return on investment, and demonstrate the impact of marketing efforts on overall business outcomes.

Proscia

Series B in 2020
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Wash Cycle Laundry

Series A in 2020
Wash Cycle Laundry Inc. is a Philadelphia-based company that offers laundry, linen rental, and dry cleaning services for both residential and commercial clients. Established in 2012, the company provides a range of services, including washing clothes, sheets, towels, and janitorial supplies, along with campus laundry plans and managed on-premise laundry solutions. It caters to a diverse clientele, including universities, hospitals, hotels, fitness centers, and individual customers. Notably, Wash Cycle Laundry distinguishes itself by using eco-friendly detergents and non-toxic solvents for its cleaning processes, avoiding harmful chemicals commonly used in the industry. The company also operates an additional location in Washington, D.C., and is committed to sustainable practices in its operations.

ExpressCells

Venture Round in 2020
ExpressCells, Inc. is a biotechnology company based in Philadelphia, Pennsylvania, established in 2018 by Oscar Perez-Leal and Matt Handel. The firm specializes in genetic engineering to develop custom knock-in cell lines that facilitate drug discovery and biological research. Utilizing advanced gene-editing technology, ExpressCells makes precise modifications to a cell's genome, enabling the insertion of new genes through a patent-pending plasmid system. This innovative approach allows researchers to visualize proteins and organelles within cells, providing valuable insights that enhance disease modeling and accelerate drug development efforts.

Thermalin

Convertible Note in 2020
Thermalin, Inc. is a biotechnology company based in Cleveland, Ohio, founded in 2010, that specializes in developing innovative insulin therapies for individuals with Type 1 and Type 2 diabetes. The company aims to disrupt the insulin and insulin delivery market with its first-in-class, ultra-rapid acting insulin, which is stabilized and highly concentrated. This new insulin formulation is designed for use in a disposable, postage-stamp-sized glucose management system and can also be utilized in existing insulin pumps. In addition to its lead program, Thermalin is exploring partnerships to develop no-cold-chain basal and mix insulins, as well as glucose-responsive insulins. By creating insulin analogs that do not require refrigeration and are rapidly absorbed, Thermalin seeks to reduce the burden of insulin therapy, thereby improving patient adherence and health outcomes.

Yellowdig

Convertible Note in 2020
Yellowdig is a software platform that enhances peer learning outcomes by creating a social layer on top of existing enterprise learning systems utilized by colleges, universities, and organizations. Established in 2015 and based in Philadelphia, Pennsylvania, Yellowdig focuses on providing a private and secure experience tailored for higher education institutions. The platform fosters collaborative learning environments, encouraging student engagement and retention while enhancing their understanding of current affairs. By integrating with established learning systems, Yellowdig transforms traditional classrooms into vibrant learning communities.

Simply Good Jars

Convertible Note in 2020
Simply Good Jars is a B-Corp company focused on providing healthy, ready-to-eat meals through reusable and returnable packaging. The company utilizes smart refrigerated kiosks strategically placed in offices, transit centers, universities, and health systems to deliver its chef-crafted food products to local communities. Committed to sustainability, Simply Good Jars aims to change consumer habits by implementing zero-waste practices in its operations. For every jar returned for reuse, the company supports food assistance efforts, ensuring that no packaging materials contribute to landfill waste. By promoting eco-friendly consumption, Simply Good Jars strives to offer convenient meal options that are beneficial for both individuals and the planet.

Biomeme

Convertible Note in 2020
Biomeme Inc., founded in 2012 and based in Philadelphia, Pennsylvania, offers an innovative platform for molecular DNA diagnostics and on-site disease tracking through a smartphone. The company's technology includes a real-time PCR thermocycler that connects to an iPhone, alongside a docking station and a mobile app for controlling the system and analyzing results. Biomeme provides targeted test kits that allow users to prepare samples and identify pathogens or diseases based on their specific DNA or RNA signatures. This end-to-end DNA testing solution enables mobile testing at the point-of-need across various sectors, including healthcare, agriculture, veterinary medicine, environmental monitoring, and education. By facilitating lab-grade molecular processes, Biomeme enhances real-time disease surveillance and diagnostics.

Genome Profiling

Convertible Note in 2020
Genome Profiling, LLC is a bioinformatics company specializing in the discovery of novel epigenetic biomarkers to aid in the diagnosis, treatment, and prediction of chronic and life-threatening diseases. Established in 2012 and located in Wayne, Pennsylvania, the company offers GenPro Analytics, a software platform designed for scientists and medical professionals. This platform improves the sensitivity, specificity, and accuracy of disease prediction and monitoring while also being cost-effective. Genome Profiling is notable for its innovative approach, combining a proprietary pre-NGS gDNA preparation kit with advanced NGS data analytics algorithms. This integration allows a single NGS run to generate comprehensive data for both genomic variant analysis and epigenetic research, positioning the company at the forefront of the emerging epigenetic biomarker market.

ReturnLogic

Seed Round in 2020
ReturnLogic is a developer of a cloud-based returns management platform designed to transform the returns process for retailers. By leveraging artificial intelligence and an API-first approach, the platform automates workflows for customer service and warehouse teams, facilitating an easy returns process for both warranty requests and general returns. This innovative solution addresses the challenges of retail returns, providing visibility and optimization that allow e-commerce retailers and brands to enhance productivity and improve their bottom-line growth. ReturnLogic aims to turn returns from a cumbersome task into a strategic asset for businesses in the retail sector.

LoanLogics

Convertible Note in 2020
LoanLogics, Inc. is a provider of innovative mortgage loan software products and services aimed at enhancing the efficiency and quality of the mortgage industry. Based in Trevose, Pennsylvania, the company offers several key platforms, including LoanDecisions for product eligibility and mortgage pricing, and LoanHD for real-time loan quality management. Its solutions are designed to automate key processes, thereby reducing loan defects and costs while managing risks in the manufacturing, acquisition, and sale of loan assets. LoanLogics serves a diverse clientele, including residential mortgage lenders, servicers, insurers, and investors, and has established strategic partnerships to enhance its offerings. Founded in 2006 and originally named Aklero Risk Analytics, LoanLogics rebranded in 2013 to reflect its focus on comprehensive mortgage solutions.

FEMSelect

Convertible Note in 2020
FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.

Burrow

Series B in 2020
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

OWIT Global

Series A in 2020
OWIT Global is a provider of innovative insurance technology solutions aimed at enhancing and future-proofing insurance processing. Founded in 2018 and headquartered in West Hartford, Connecticut, the company specializes in offering a range of cloud-based microservices tailored for the global insurance industry. These microservices can function independently or integrate seamlessly with existing systems, allowing for flexible and targeted solutions. OWIT Global’s offerings include Bordereaux Management, Cyber Rating & Distribution, Accident & Health and Specialty Point of Sale, Document Generation, and Portal Configuration, among others. The company's platform facilitates data ingestion and transformation, supporting the insurance industry's evolving needs and the integration of emerging technologies such as blockchain and smart contracts.

Immunome

Series A in 2020
Immunome Inc., founded in 2006 and headquartered in Exton, Pennsylvania, is a biotechnology company focused on discovering, developing, and commercializing highly targeted and native human cancer antibodies against universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that target them. Additionally, Immunome employs ScreenMab multiplex functional screening technology to pinpoint monoclonal antibodies with high specificity for tumor neoantigens.

Lia

Convertible Note in 2020
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

AgileSwitch

Venture Round in 2020
AgileSwitch, LLC specializes in the design and manufacture of gate drivers for silicon carbide power modules, focusing on enhancing performance and efficiency in electric vehicles and renewable energy applications. Founded in 2011 and based in Philadelphia, Pennsylvania, the company offers a range of products including analog stack electronics and evaluation kits for both analog and digital intelligent power modules (IPM). AgileSwitch's plug and play drivers are recognized for their efficiency and reliability, with the ability to be fully customized to meet diverse customer needs. The company is committed to ongoing product development, continuously expanding its offerings to serve various high-reliability markets such as solar inverters, wind turbines, energy storage, and motor drives, ultimately helping clients reduce power loss and improve the performance of electronic equipment.

Annovis Bio

Post in 2020
Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.

Virion Therapeutics

Convertible Note in 2019
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Immunome

Series A in 2019
Immunome Inc., founded in 2006 and headquartered in Exton, Pennsylvania, is a biotechnology company focused on discovering, developing, and commercializing highly targeted and native human cancer antibodies against universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that target them. Additionally, Immunome employs ScreenMab multiplex functional screening technology to pinpoint monoclonal antibodies with high specificity for tumor neoantigens.

KickUp

Series A in 2019
KickUp, Inc. operates a collaboration platform tailored for K-12 school districts, focusing on the design, coordination, and assessment of professional learning activities. The platform provides educational leaders with actionable insights into the effectiveness of their programs, allowing for informed decision-making. It enables professional development teams to leverage analytics for customizing support for teachers, aligning with strategic goals, and integrating real-time data from surveys. KickUp's services aim to enhance the professional learning experience, ensuring that innovative ideas translate into measurable outcomes in the classroom. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as Pedagology, LLC before rebranding in 2015.

Intrommune Therapeutics

Series A in 2019
Intrommune Therapeutics is a clinical-stage biotechnology company focused on developing safe and effective treatments for food allergies. The company’s Oral Mucosal Immunotherapy (OMIT) platform utilizes a specially formulated toothpaste that allows patients to safely expose their immune systems to allergenic proteins while maintaining oral hygiene. The primary product under development, INT301, targets peanut allergy, addressing a significant unmet need in a market with limited treatment options. Currently, only one FDA-approved product for food allergies exists, which requires patients to ingest peanut protein, a method that many find difficult and risky. Intrommune's innovative approach aims to provide a more accessible and manageable solution for patients and their families, reducing the fear associated with food allergies. The company is conducting a Phase 1b study for INT301, with important developmental milestones expected in the coming year.

Simply Good Jars

Seed Round in 2019
Simply Good Jars is a B-Corp company focused on providing healthy, ready-to-eat meals through reusable and returnable packaging. The company utilizes smart refrigerated kiosks strategically placed in offices, transit centers, universities, and health systems to deliver its chef-crafted food products to local communities. Committed to sustainability, Simply Good Jars aims to change consumer habits by implementing zero-waste practices in its operations. For every jar returned for reuse, the company supports food assistance efforts, ensuring that no packaging materials contribute to landfill waste. By promoting eco-friendly consumption, Simply Good Jars strives to offer convenient meal options that are beneficial for both individuals and the planet.

Ophidion

Venture Round in 2019
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

WizeHive

Convertible Note in 2019
WizeHive, Inc. is a technology company that specializes in developing and operating cloud-based software platforms designed to help organizations streamline their business processes. Founded in 2009 and based in Conshohocken, Pennsylvania, WizeHive offers a range of software solutions including grants management, scholarship management, awards management, fellowship management, internship management, and accreditation management systems. These tools facilitate the collection, review, and organization of applications and records for various programs, catering to foundations, universities, and government agencies. WizeHive's flagship product, Zengine, is a user-friendly platform that enables non-technical users to build custom applications while allowing developers to enhance functionality through integrations and plugins. By automating administrative tasks and improving organizational efficiency, WizeHive helps its clients save time and resources.

Wash Cycle Laundry

Convertible Note in 2019
Wash Cycle Laundry Inc. is a Philadelphia-based company that offers laundry, linen rental, and dry cleaning services for both residential and commercial clients. Established in 2012, the company provides a range of services, including washing clothes, sheets, towels, and janitorial supplies, along with campus laundry plans and managed on-premise laundry solutions. It caters to a diverse clientele, including universities, hospitals, hotels, fitness centers, and individual customers. Notably, Wash Cycle Laundry distinguishes itself by using eco-friendly detergents and non-toxic solvents for its cleaning processes, avoiding harmful chemicals commonly used in the industry. The company also operates an additional location in Washington, D.C., and is committed to sustainable practices in its operations.

Burrow

Series B in 2019
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Sidecar

Series C in 2019
Sidecar Interactive, Inc. is an e-commerce technology company that specializes in providing software solutions for retailers to enhance their online marketing efforts. The company's primary offering is the Sidecar Predictive Bid Engine, which optimizes advertising bids for intelligent product groupings based on real-time data analysis. This system ensures that products receive appropriate bids to maximize visibility and return on advertising spend, while also allowing high-performing products to be managed individually. Additionally, Sidecar's solutions include dynamic product advertisements on social media platforms, enabling retailers to showcase their entire product catalogs effectively. By leveraging machine learning and extensive data analytics, Sidecar assists online retailers in managing their product listing advertisement campaigns, ultimately improving business performance and efficiency. Founded in 2007 and based in Philadelphia, Pennsylvania, Sidecar was previously known as Snipi, Inc. until its name change in 2011.

ExpressCells

Series A in 2019
ExpressCells, Inc. is a biotechnology company based in Philadelphia, Pennsylvania, established in 2018 by Oscar Perez-Leal and Matt Handel. The firm specializes in genetic engineering to develop custom knock-in cell lines that facilitate drug discovery and biological research. Utilizing advanced gene-editing technology, ExpressCells makes precise modifications to a cell's genome, enabling the insertion of new genes through a patent-pending plasmid system. This innovative approach allows researchers to visualize proteins and organelles within cells, providing valuable insights that enhance disease modeling and accelerate drug development efforts.

Illumina Radiopharmaceuticals

Seed Round in 2019
Illumina Radiopharmaceuticals

Simply Good Jars

Pre Seed Round in 2018
Simply Good Jars is a B-Corp company focused on providing healthy, ready-to-eat meals through reusable and returnable packaging. The company utilizes smart refrigerated kiosks strategically placed in offices, transit centers, universities, and health systems to deliver its chef-crafted food products to local communities. Committed to sustainability, Simply Good Jars aims to change consumer habits by implementing zero-waste practices in its operations. For every jar returned for reuse, the company supports food assistance efforts, ensuring that no packaging materials contribute to landfill waste. By promoting eco-friendly consumption, Simply Good Jars strives to offer convenient meal options that are beneficial for both individuals and the planet.

Lia

Seed Round in 2018
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

Virion Therapeutics

Series A in 2018
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Proscia

Series A in 2018
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Burrow

Series A in 2018
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.